Penobscot Investment Management Company, Inc. Amgen Inc Transaction History

Penobscot Investment Management Company, Inc.

$1.06 Billion
Q3 2024

A detailed history of Penobscot Investment Management Company, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Penobscot Investment Management Company, Inc. holds 16,413 shares of AMGN stock, worth $4.83 Million. This represents 0.5% of its overall portfolio holdings.

Number of Shares

16,413

Previous 16,116 1.84%

Holding current value

$4.83 Million

Previous $5.04 Million 5.02%

% of portfolio

0.5%

Previous 0.51%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$309.38 - $337.38 $91,885 - $100,201	297 Added 1.84%	16,413 $5.29 Million
Q2 2024 Aug 13, 2024	SELL	$262.75 - $319.31 $89,335 - $108,565	-340 Reduced 2.07%	16,116 $5.04 Million
Q1 2024 May 13, 2024	SELL	$268.87 - $324.56 $642,599 - $775,698	-2,390 Reduced 12.68%	16,456 $4.68 Million
Q4 2023 Feb 05, 2024	SELL	$255.7 - $288.46 $56,509 - $63,749	-221 Reduced 1.16%	18,846 $5.43 Million
Q3 2023 Nov 08, 2023	BUY	$218.65 - $271.46 $184,977 - $229,655	846 Added 4.64%	19,067 $5.12 Million
Q2 2023 Aug 10, 2023	SELL	$214.27 - $253.37 $163,916 - $193,828	-765 Reduced 4.03%	18,221 $4.05 Million
Q1 2023 May 08, 2023	SELL	$225.79 - $275.2 $8,580 - $10,457	-38 Reduced 0.2%	18,986 $4.59 Million
Q4 2022 Feb 13, 2023	SELL	$229.03 - $291.01 $49,241 - $62,567	-215 Reduced 1.12%	19,024 $5 Million
Q3 2022 Nov 02, 2022	SELL	$224.46 - $253.15 $6,733 - $7,594	-30 Reduced 0.16%	19,239 $4.34 Million
Q2 2022 Aug 11, 2022	BUY	$230.71 - $256.74 $17,764 - $19,768	77 Added 0.4%	19,269 $4.69 Million
Q1 2022 May 11, 2022	SELL	$219.27 - $242.57 $413,323 - $457,244	-1,885 Reduced 8.94%	19,192 $4.64 Million
Q4 2021 Feb 11, 2022	SELL	$198.88 - $227.6 $574,564 - $657,536	-2,889 Reduced 12.05%	21,077 $4.74 Million
Q3 2021 Nov 08, 2021	SELL	$212.27 - $248.7 $1.55 Million - $1.82 Million	-7,324 Reduced 23.41%	23,966 $5.1 Million
Q2 2021 Aug 09, 2021	SELL	$233.58 - $259.14 $626,461 - $695,013	-2,682 Reduced 7.89%	31,290 $7.63 Million
Q1 2021 May 07, 2021	BUY	$221.91 - $258.6 $54,811 - $63,874	247 Added 0.73%	33,972 $8.45 Million
Q4 2020 Feb 08, 2021	BUY	$216.38 - $257.67 $138,915 - $165,424	642 Added 1.94%	33,725 $7.75 Million
Q3 2020 Nov 03, 2020	BUY	$234.65 - $260.95 $70,160 - $78,024	299 Added 0.91%	33,083 $8.41 Million
Q2 2020 Aug 04, 2020	SELL	$197.81 - $242.74 $50,243 - $61,655	-254 Reduced 0.77%	32,784 $7.73 Million
Q1 2020 May 07, 2020	BUY	$182.24 - $241.7 $284,841 - $377,777	1,563 Added 4.97%	33,038 $6.7 Million
Q4 2019 Feb 04, 2020	BUY	$189.21 - $243.2 $162,342 - $208,665	858 Added 2.8%	31,475 $7.59 Million
Q3 2019 Nov 05, 2019	BUY	$174.11 - $208.62 $80,961 - $97,008	465 Added 1.54%	30,617 $5.93 Million
Q2 2019 Aug 02, 2019	BUY	$166.7 - $195.41 $111,855 - $131,120	671 Added 2.28%	30,152 $5.56 Million
Q1 2019 May 13, 2019	BUY	$180.87 - $203.88 $152,835 - $172,278	845 Added 2.95%	29,481 $5.6 Million
Q4 2018 Feb 12, 2019	BUY	$178.4 - $208.25 $144,504 - $168,682	810 Added 2.91%	28,636 $5.57 Million
Q3 2018 Nov 01, 2018	BUY	$185.29 - $208.89 $73,189 - $82,511	395 Added 1.44%	27,826 $5.77 Million
Q2 2018 Aug 07, 2018	BUY	$166.05 - $186.51 $24,907 - $27,976	150 Added 0.55%	27,431 $5.06 Million
Q1 2018 May 07, 2018	BUY	$169.43 - $198.0 $160,280 - $187,308	946 Added 3.59%	27,281 $4.65 Million
Q4 2017 Feb 05, 2018	BUY	$168.79 - $188.59 $264,156 - $295,143	1,565 Added 6.32%	26,335 $4.58 Million
Q3 2017 Nov 02, 2017	BUY	$167.29 - $191.0 $4.14 Million - $4.73 Million	24,770	24,770 $4.62 Million

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Penobscot Investment Management Company, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Penobscot Investment Management Company, Inc. with notifications on news.

Account

Penobscot Investment Management Company, Inc. Amgen Inc Transaction History